c-Myc (1.N.2) Antibody sc-70469 from Santa Cruz Biotechnology, Inc.

Product Specs
Itemc-Myc (1.N.2) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-70469
NCBI Gene Aliasesc-Myc, bHLHe39, MRTL, MYCC, Nird, Myc2, Niard
Antibody TypePrimary Antibodies
Clone1.N.2
Quantity200 µg/ml
ApplicationsWB, IP, IF
Reactivitymouse, rat, human, avian
FormatPurified
ClonalityMonoclonal
Hostmouse
Conjugate/TagUnconjugated
NCBI Full Gene Namemyelocytomatosis oncogene, MYC proto-oncogene, bHLH transcription factor
Targetc-Myc
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinomaCancer scienceJanuary 1, 2022Liao WC, Lin TJ, Liu YC, Wei YS, Chen GY, Feng HP, Chang YF, Chang HT, Wang CL, Chi HC, et al.included the following: anti–KPNA2 (sc‐55538), anti–vimentin (sc‐6260), anti–AKT 1 (sc‐5298), anti–c‐MYC (sc‐70469), and anti–GAPDH (sc‐32233), which were purchased from Santa Cruz; anti–ABCG2 (ab207732); anti–E‐cadherin

(2) Japanese encephalitis virus capsid protein interacts with non-lipidated MAP1LC3 on replication membranes and lipid dropletsThe Journal of general virologyJanuary 1, 2021Sarkar R, Sharma KB, Kumari A, Asthana S, Kalia M.

(3) TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancerCancer gene therapyApril 1, 2020Zhang T, Liu C, Yu Y, Geng J, Meng Q, Xu S, Zhou F, Chen Y, Jin S, Shen J, et al.

(4) CPF impedes cell cycle re‐entry of quiescent lung cancer cells through transcriptional suppression of FACT and c‐MYCJournal of Cellular and Molecular MedicineFebruary 1, 2020Ling Bi et al.3686) were from Cell Signaling Technology; Antibodies against SKP2 (Cat. #: sc7164) and c‐MYC (Cat. #: sc70469) were from Santa Cruz Biotechnology. GAPDH antibody (Cat. #: ab8245) was obtained from Abcam. 2.9 Chromatin

(5) The histone chaperone complex FACT promotes proliferative switch of G(0) cancer cellsInternational journal of cancerJuly 1, 2019Bi L, Xie C, Yao M, Thae Hnit SS, Vignarajan S, Wang Y, Wang Q, Xi Z, Xu H, Li Z, et al.

(6) The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signalingJournal of hepatologyMay 1, 2019Wu J, Zhu P, Lu T, Du Y, Wang Y, He L, Ye B, Liu B, Yang L, Wang J, et al.

(7) HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domainMolecular medicine reportsMarch 1, 2019Deng Q, Luo L, Quan Z, Liu N, Du Z, Sun W, Luo C, Wu X.cat. no. 22576-1-AP), anti-c-myc (1:1000; Santa Cruz Biotechnology, Inc., Dallas, TX, USA, cat. no. sc-70469), anti-β-actin (1:1,000; Abcam, cat. no. ab8226), anti-cyclinD1 (1:1,000; Santa Cruz Biotechnology, Inc

(8) TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and TumorigenesisGastroenterologyFebruary 1, 2019Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, et al.

(9) p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cellsOncology lettersJanuary 1, 2019Jiang D, Song Y, Cao W, Wang X, Jiang D, Lv Z, Yang Z, Li F.antibodies, including anti-p21, anti-p14, anti-MYC and anti-β-actin (cat. nos. sc-53393, sc-71808, sc-70469 and sc-58673, respectively; all 1:200 dilution; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), and

(10) Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate CancerPathology oncology research : PORJanuary 1, 2019Ren K, Gou X, Xiao M, He W, Kang J.

(11) LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesisNature cell biologyOctober 1, 2018Zhu P, Wu J, Wang Y, Zhu X, Lu T, Liu B, He L, Ye B, Wang S, Meng S, et al.

(12) Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cellsMolecular medicine reportsFebruary 1, 2018Chen X, Gu N, Xue C, Li BR.

(13) Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cellsThe Turkish journal of gastroenterology : the official journal of Turkish Society of GastroenterologyNovember 1, 2017Alaca N, Özbeyli D, Uslu S, Şahin HH, Yiğittürk G, Kurtel H, Öktem G, Çağlayan Yeğen B.

(14) Distinct outcomes of CRL-Nedd8 pathway inhibition reveal cancer cell plasticityCell death & diseaseDecember 1, 2016Rulina AV, Mittler F, Obeid P, Gerbaud S, Guyon L, Sulpice E, Kermarrec F, Assard N, Dolega ME, Gidrol X, et al.

(15) Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cellsCancer biology & therapyJanuary 1, 2015Chong KY, Hsu CJ, Hung TH, Hu HS, Huang TT, Wang TH, Wang C, Chen CM, Choo KB, Tseng CP.

(16) Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27European journal of pharmacologyMarch 15, 2012Li XW, Hu CP, Wu WH, Zhang WF, Zou XZ, Li YJ.

Be the First to Write a Review!

c-Myc (1.N.2) Antibody

c-Myc (1.N.2) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (16)

Reviews

c-Myc (1.N.2) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map